Don’t Jump to Voquezna for Erosive GERD

Rx vonoprazan (Voquezna) will be touted as the first acid suppressant with a new mechanism of action in over 30 years.

It’s the first potassium-competitive acid blocker (PCAB)...and is now approved for erosive esophagitis.

Think of vonoprazan as a “fancy PPI”...with some differences.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote